Efficacy and Safety of SAR441344 in the Treatment of Systemic Lupus Erythematosus
18-70 years
All genders
Phase 2
Interventional
This is a multinational, randomized, placebo-controlled, parallel treatment, Phase 2, double-blind, 2 arm study evaluating the efficacy and safety of SAR441344 in comparison with placebo in the treatment of participants aged 18 to 70 years with active Systemic Lupus Erythematosus (SLE). Study details include: Study duration: 36 weeks Treatment duration: …